Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria

Article Properties
  • Language
    English
  • Publication Date
    2018/02/01
  • Indian UGC (Journal)
  • Refrences
    99
  • Citations
    108
  • Alan J Thompson
  • Brenda L Banwell
  • Frederik Barkhof
  • William M Carroll
  • Timothy Coetzee
  • Giancarlo Comi
  • Jorge Correale
  • Franz Fazekas
  • Massimo Filippi
  • Mark S Freedman
  • Kazuo Fujihara
  • Steven L Galetta
  • Hans Peter Hartung
  • Ludwig Kappos
  • Fred D Lublin
  • Ruth Ann Marrie
  • Aaron E Miller
  • David H Miller
  • Xavier Montalban
  • Ellen M Mowry
  • Per Soelberg Sorensen
  • Mar Tintoré
  • Anthony L Traboulsee
  • Maria Trojano
  • Bernard M J Uitdehaag
  • Sandra Vukusic
  • Emmanuelle Waubant
  • Brian G Weinshenker
  • Stephen C Reingold
  • Jeffrey A Cohen
Cite
Thompson, Alan J, et al. “Diagnosis of Multiple Sclerosis: 2017 Revisions of the McDonald Criteria”. The Lancet Neurology, vol. 17, no. 2, 2018, pp. 162-73, https://doi.org/10.1016/s1474-4422(17)30470-2.
Thompson, A. J., Banwell, B. L., Barkhof, F., Carroll, W. M., Coetzee, T., Comi, G., Correale, J., Fazekas, F., Filippi, M., Freedman, M. S., Fujihara, K., Galetta, S. L., Hartung, H. P., Kappos, L., Lublin, F. D., Marrie, R. A., Miller, A. E., Miller, D. H., Montalban, X., … Cohen, J. A. (2018). Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. The Lancet Neurology, 17(2), 162-173. https://doi.org/10.1016/s1474-4422(17)30470-2
Thompson AJ, Banwell BL, Barkhof F, Carroll WM, Coetzee T, Comi G, et al. Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. The Lancet Neurology. 2018;17(2):162-73.
Journal Categories
Medicine
Internal medicine
Neurosciences
Biological psychiatry
Neuropsychiatry
Medicine
Internal medicine
Neurosciences
Biological psychiatry
Neuropsychiatry
Neurology
Diseases of the nervous system
Refrences
Refrences Analysis
The category Medicine: Internal medicine: Neurosciences. Biological psychiatry. Neuropsychiatry 93 is the most frequently represented among the references in this article. It primarily includes studies from Neurology The chart below illustrates the number of referenced publications per year.
Refrences used by this article by year
Citations
Citations Analysis
The first research to cite this article was titled Therapeutic Advances and Challenges in the Treatment of Progressive Multiple Sclerosis and was published in 2018. The most recent citation comes from a 2024 study titled Therapeutic Advances and Challenges in the Treatment of Progressive Multiple Sclerosis . This article reached its peak citation in 2023 , with 42 citations.It has been cited in 57 different journals, 42% of which are open access. Among related journals, the Scientific Reports cited this research the most, with 12 citations. The chart below illustrates the annual citation trends for this article.
Citations used this article by year